Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
Condition(s):Multiple MyelomaLast Updated:December 5, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:December 5, 2016Completed
Condition(s):Acute Myelogenous Leukemia; Chemotherapy-induced Nausea and VomitingLast Updated:August 7, 2012Completed
Condition(s):Malignant NeoplasmLast Updated:May 8, 2023Completed
Condition(s):Chemotherapy-induced Nausea and Vomiting, ProphylaxisLast Updated:August 4, 2021Completed
Condition(s):Antiemetic; Postoperative Nausea and VomitingLast Updated:October 6, 2020Unknown status
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:November 23, 2016Unknown status
Condition(s):Substance-Related DisordersLast Updated:June 5, 2017Completed
Condition(s):Morphine Adverse ReactionLast Updated:April 9, 2015Completed
Condition(s):Hematopoietic/Lymphoid Cancer; Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:May 7, 2020Completed
Condition(s):Gallbladder DiseasesLast Updated:May 11, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.